Study Watch vs iCAC Device
AI Verdict
Choose Study Watch if…
Choose the Verily Study Watch if your clinical research requires continuous, high-fidelity physiological data collection from participants over extended periods. This device is ideal for studies focused on developing and validating AI-enabled precision health solutions that rely on multi-modal sensor data like ECG, heart rate, and movement for in-depth analysis.
View Study Watch →Choose iCAC Device if…
Choose Bunkerhill Health's iCAC Device if you aim to opportunistically screen for cardiovascular disease risk by leveraging existing, routine non-contrast chest CT scans. This AI algorithm is best suited for healthcare systems looking to efficiently identify and quantify coronary artery calcium, providing valuable adjunctive information to radiologists for early detection and intervention.
View iCAC Device →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Study Watch | iCAC Device |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
iCAC DeviceThe iCAC Device integrates seamlessly into existing radiology workflows by analyzing routine CT scans, requiring minimal additional effort from clinicians. In contrast, the Study Watch, as a wearable, necessitates patient compliance for wearing and charging, and involves logistical management for device deployment and data collection in a research setting.
Clinical Value
iCAC DeviceThe iCAC Device offers direct, actionable clinical value by quantifying coronary artery calcium from existing CT scans, a validated marker for cardiovascular disease risk. This provides immediate diagnostic and prognostic information to clinicians. While Study Watch provides valuable continuous physiological data for research, its direct clinical actionability for individual patient management is less immediate compared to iCAC's specific diagnostic output.
Pricing & Value
iCAC DeviceBoth tools lack public pricing transparency, making a direct cost comparison impossible. However, the iCAC Device offers potentially higher value by leveraging existing, routinely acquired CT scans to provide critical cardiovascular risk information without requiring additional patient procedures or dedicated hardware. This opportunistic screening approach can maximize the utility of existing data, potentially leading to cost efficiencies in risk assessment.
Enterprise Readiness
iCAC DeviceThe iCAC Device demonstrates strong enterprise readiness through its FDA clearance and direct integration with standard healthcare IT systems like PACS, DICOM routers, and EHRs via the Carebricks platform. While Study Watch is also FDA-cleared and states HIPAA compliance, the ongoing lawsuit alleging BAA/HIPAA breaches against Verily introduces a significant risk factor for enterprise adoption.
Innovation
iCAC DeviceThe iCAC Device demonstrates greater innovation by leveraging deep-learning AI to opportunistically identify and quantify coronary artery calcium from existing, routine CT scans. This transforms readily available imaging data into a powerful cardiovascular risk assessment tool without requiring additional patient procedures. While Study Watch offers advanced continuous monitoring, the concept of opportunistic screening using AI on existing data represents a more disruptive and broadly impactful innovation in clinical practice.
Support & Docs
TieNeither the provided structured facts nor general web searches yielded specific public information regarding the level of support or documentation available for either the Verily Study Watch or the Bunkerhill Health iCAC Device. Therefore, it is not possible to distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Study Watch | iCAC Device |
|---|---|---|
| Name | Study Watch | iCAC Device |
| Company | Verily | Bunkerhill Health |
| Description | Verily Study Watch is a prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform. | Bunkerhill Health's iCAC Device is an FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection. |
| Tagline | AI-native precision health | Building healthcare's system of action with AI for clinical reasoning and action. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI |
| Specialties | Cardiology, Neurology, Sleep Medicine | Cardiology, Radiology |
| Key Features | Continuous physiological monitoring, Multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements), Long battery life (up to one week), Internal data storage and encryption, Cloud-based data processing with algorithms and machine learning, On-demand single-channel ECG, Irregular pulse monitor, E-ink display for minimal power consumption | Estimates presence and quantity of coronary artery calcium (CAC), Analyzes routine, non-contrast, non-gated chest CT scans, Utilizes deep-learning algorithms for analysis, Provides adjunctive information to radiologists, Outputs visual representation of estimated CAC segmentation, Delivers exact and four-category quantitative estimates of CAC burden in Agatston units, Integrates with EHRs via the Carebricks platform, Supports opportunistic identification of CAC from existing CT scans |
Videos
Demos, reviews, and walkthroughs featuring Study Watch and iCAC Device.